Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026)

Rigel Pharmaceuticals' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.59 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 50.72% year-over-year to 0.59; the TTM figure through Mar 2026 stood at 0.59 (down 50.72% YoY), while the FY2025 annual figure was 0.87, down 31.88% from the prior year.
• Asset Utilization Ratio was 0.59 for Q1 2026 at Rigel Pharmaceuticals, down from 0.78 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.4 in Q2 2025 to a low of 0.54 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.98 across 5 years, with a median of 1.01 in 2023.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio jumped 87.13% in 2023, then plunged 50.72% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.96 in 2022, then advanced by 4.45% to 1.01 in 2023, then increased by 17.57% to 1.18 in 2024, then slumped by 34.14% to 0.78 in 2025, then slipped by 24.35% to 0.59 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.59 (Q1 2026), 0.78 (Q4 2025), and 1.26 (Q3 2025), per Business Quant data.